Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2019 Earnings Conference Call March 12, 2020 4:30 PM ET Company Participants Donald Notman - Chief Financial Officer Antony Mattessich - President and Chief Executive Officer Michael Goldstein - Chief Medical Officer Scott Corning - Senior Vice President, Commercial Conference Call Participants Joe Catanzaro - Piper Jaffray Dane Leone - Raymond James & Associates, Inc. Yi Chen - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Thank you for standing by ...

(NASDAQ: OCUL) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM JEFFERIES LONDON HC CONFERENCE DONALD NOTMAN CFO NOVEMBER 21, 2019 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans and prospects for the Company, including the commercialization of DEXTENZA®, ReSure® Sealant, or any of the Company's product candidates, including the impact of and restructuring costs and potential future savings associated with the Company's operational restructuri ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2019 Results Earnings Conference Call November 12, 2019 8:00 AM ET Company Participants Donald Notman - Chief Financial Officer Antony Mattessich - President and Chief Executive Officer Michael Goldstein - Chief Medical Officer Conference Call Participants Joe Catanzaro - Piper Jaffray Operator Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ocular Therapeutix's Third Quarter Earnings Conference Call. At this time, all participants ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Donald Notman - Chief Financial Officer Antony Mattessich - President and Chief Executive Officer Scott Corning - Senior Vice President, Commercial Michael Goldstein - Chief Medical Officer Conference Call Participants Charles Frantzreb - Piper Jaffray Yi Chen - H.C. Wainwright & Co. Operator Good afternoon, ladies and gentlemen. Thank you for standing by. And welcome to the Ocular Therapeu ...

Start Time: 08:30 January 1, 0000 9:04 AM ET Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q1 2019 Earnings Conference Call May 10, 2019, 08:30 AM ET Company Participants Antony Mattessich - President and CEO Donald Notman - CFO Scott Corning - SVP, Commercial Michael Goldstein - CMO Conference Call Participants Dan Leone - Raymond James Yi Chen - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Thank you for standing by. And welcome to the Ocular Therapeutix First Quarter Earnings Conference Call. A ...

( N A S D AQ: O C U L ) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM MICHAEL GOLDSTEIN, M.D., M.B.A. CHIEF MEDICAL OFFICER MARCH 2019 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans and prospects for the Company, including the commercialization of DEXTENZA®, ReSure Sealant, or any of the Company's product candidates, development and regulatory status of the Company's product candidates, such as the Company's anticipated commercial launch o ...

Ocular Therapeutix (NASDAQ:OCUL) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Antony Mattessich - President and Chief Executive Officer Donald Notman - Chief Financial Officer Scott Corning - Senior Vice President, Commercial Michael Goldstein - Chief Medical Officer Conference Call Participants Adnan Butt - Guggenheim Securities Dan Leone - Raymond James Operator Good afternoon, ladies and gentlemen, thank you for standing by. And welcome to the Ocular Therapeutix Fourth Q ...